Black Friday Sale - Ends Soon!
-35% Off Everything
Moderna, Inc. (MRNA)
Last Price$43.1(0.8%)
Market Cap$30.4B
MRNA overview
Crunching data... Almost there!
1W 4.7%
1M (22.0%)
6M (70.9%)
YTD (61.7%)
1Y (45.5%)
3Y (88.3%)
5Y 111.5%
10Y 131.5%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
MRNA key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
MRNA Intrinsic value
MRNA Intrinsic value overview
MRNA Historical intrinsic value
MRNA Financials
MRNA Income statement
Crunching data... Almost there!
MRNA Balance sheet
Crunching data... Almost there!
MRNA Cash flow statement
Crunching data... Almost there!
MRNA Financial ratios
MRNA Growth
Crunching data... Almost there!
MRNA Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more MRNA fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Moderna, Inc. (MRNA) stock?
As of today, intrinsic value of Moderna, Inc. is $85.7.
Is Moderna, Inc. (MRNA) stock undervalued or overvalued?
As of today, Moderna, Inc. is undervalued by 99.1%, compared to the current market share price of $43.1.
What is Moderna, Inc. (MRNA) stock rating?
As of today, Moderna, Inc. has a stock rating of 4 (out of 10), which is considered Good.
is Moderna, Inc. (MRNA) a good stock to buy?
As of today, Moderna, Inc. has a Good stock rating, which is 99.1% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.